/
/
/

Krsnaa Diagnostics Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--16%16%
--4%37%
--10%-5%-32%
9%9%8%9%

Peer Comparison

Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
KRSNAA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,664₹126300 Cr60.4540.39207.67₹1942 Cr
992₹96763 Cr66.423.3119.84₹1442 Cr
725.5₹95496 Cr107.021.9611.95₹892 Cr
911.6₹68901 Cr65.753.5320.1₹1042 Cr
790₹68592 Cr215.240.316.76₹464 Cr
1,869₹38439 Cr47.110.1465.36₹806 Cr
1,479.6₹38149 Cr68.595.9129.85₹556 Cr
1,877₹32259 Cr59.5310.1142.51₹505 Cr
765.4₹32231 Cr157.771.0412.74₹241 Cr
510.15₹16249 Cr109.521.4313.88₹133 Cr
558.05₹1777 Cr18.245.159.88₹102 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
₹236 Cr₹193 Cr₹181 Cr₹206 Cr₹193 Cr₹186 Cr₹175 Cr₹186 Cr₹170 Cr₹166 Cr₹158 Cr₹155 Cr₹140 Cr₹133 Cr₹118 Cr₹123 Cr₹113 Cr₹108 Cr₹106 Cr₹108 Cr₹132 Cr
₹7 Cr₹31 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹9 Cr₹5 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr
₹243 Cr₹224 Cr₹185 Cr₹210 Cr₹197 Cr₹190 Cr₹184 Cr₹191 Cr₹178 Cr₹171 Cr₹162 Cr₹160 Cr₹144 Cr₹139 Cr₹123 Cr₹127 Cr₹117 Cr₹112 Cr₹111 Cr₹111 Cr₹136 Cr
₹206 Cr₹160 Cr₹157 Cr₹170 Cr₹163 Cr₹155 Cr₹152 Cr₹159 Cr₹149 Cr₹141 Cr₹142 Cr₹143 Cr₹124 Cr₹113 Cr₹103 Cr₹105 Cr₹97 Cr₹91 Cr₹87 Cr₹87 Cr₹101 Cr
₹65 Cr₹86 Cr₹50 Cr₹63 Cr₹55 Cr₹57 Cr₹54 Cr₹54 Cr₹50 Cr₹48 Cr₹41 Cr₹36 Cr₹36 Cr₹40 Cr₹34 Cr₹35 Cr₹32 Cr₹32 Cr₹34 Cr₹35 Cr₹45 Cr
₹15 Cr₹12 Cr₹8 Cr₹8 Cr₹6 Cr₹7 Cr₹6 Cr₹6 Cr₹5 Cr₹7 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹8 Cr₹6 Cr
₹22 Cr₹52 Cr₹20 Cr₹32 Cr₹27 Cr₹29 Cr₹25 Cr₹25 Cr₹23 Cr₹23 Cr₹16 Cr₹13 Cr₹18 Cr₹24 Cr₹18 Cr₹20 Cr₹19 Cr₹20 Cr₹21 Cr₹17 Cr₹29 Cr
₹17 Cr₹42 Cr₹15 Cr₹24 Cr₹21 Cr₹21 Cr₹19 Cr₹20 Cr₹18 Cr₹19 Cr₹13 Cr₹10 Cr₹15 Cr₹19 Cr₹14 Cr₹15 Cr₹14 Cr₹18 Cr₹16 Cr₹13 Cr₹22 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022
₹16 Cr₹16 Cr₹16 Cr₹16 Cr
₹6 Cr₹2 Cr₹3 Cr₹2 Cr
₹860 Cr₹791 Cr₹720 Cr₹667 Cr
₹860 Cr₹791 Cr₹720 Cr₹667 Cr
₹883 Cr₹810 Cr₹739 Cr₹684 Cr
₹47 Cr₹42 Cr₹24 Cr₹33 Cr
₹19 Cr₹15 Cr₹11 Cr₹7 Cr
₹21 Cr₹21 Cr₹34 Cr₹30 Cr
₹3 Cr₹2 Cr₹1 Cr₹32 L
₹90 Cr₹79 Cr₹71 Cr₹70 Cr
₹97 Cr₹82 Cr₹62 Cr₹77 Cr
₹60 Cr₹99 Cr₹35 Cr₹42 Cr
₹139 Cr₹96 Cr₹0₹0
₹9 Cr₹4 Cr₹2 Cr₹2 Cr
₹305 Cr₹281 Cr₹99 Cr₹121 Cr
₹1278 Cr₹1170 Cr₹909 Cr₹875 Cr
₹55 Cr₹23 Cr₹4 Cr₹4 Cr
₹204 Cr₹160 Cr₹32 Cr₹41 Cr
₹971 Cr₹874 Cr₹627 Cr₹491 Cr
₹300 Cr₹226 Cr₹156 Cr₹106 Cr
₹670 Cr₹647 Cr₹471 Cr₹386 Cr
₹3 Cr₹10 Cr₹25 Cr₹28 Cr
₹32 Cr₹29 L₹29 L₹29 L
₹32 Cr₹29 L₹29 L₹29 L
₹45 Cr₹62 Cr₹26 Cr₹18 Cr
₹114 Cr₹29 Cr₹163 Cr₹109 Cr
₹864 Cr₹749 Cr₹686 Cr₹541 Cr
₹29 Cr₹36 Cr₹25 Cr₹9 Cr
₹278 Cr₹176 Cr₹73 Cr₹58 Cr
₹68 Cr₹175 Cr₹109 Cr₹242 Cr
₹30 Cr₹24 Cr₹10 Cr₹8 Cr
₹9 Cr₹10 Cr₹6 Cr₹17 Cr
₹414 Cr₹421 Cr₹223 Cr₹334 Cr
₹109 Cr₹140 Cr₹124 Cr₹213 Cr
₹1278 Cr₹1170 Cr₹909 Cr₹875 Cr
₹271₹250₹234₹217
₹271₹250₹234₹217

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022
₹103 Cr₹70 Cr₹80 Cr₹87 Cr
₹98 Cr₹70 Cr₹45 Cr₹49 Cr
-₹93 Cr-₹97 Cr-₹36 Cr-₹66 L
₹107 Cr₹43 Cr₹89 Cr₹135 Cr
₹87 Cr₹24 Cr₹76 Cr₹128 Cr
-₹100 Cr-₹129 Cr-₹109 Cr-₹241 Cr
₹14 Cr₹84 Cr-₹33 Cr₹176 Cr
₹1 Cr-₹20 Cr-₹66 Cr₹64 Cr
₹2 Cr₹23 Cr₹88 Cr₹25 Cr
₹4 Cr₹2 Cr₹23 Cr₹88 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)552.35
Volume (₹)10,169.00
High (₹)560.45
Upper Circuit661.10
Low (₹)550.05
Lower Circuit440.80
Prev Close550.95
52W High (₹)894.40
Price558.05
52W Low (₹)515.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)1777.31 Cr
Div. Yield (%)0.37
PE Ratio18.24
Debt to Equity0.23
Price to Book2.89
Book Value271.39
EPS (TTM)30.04
Face Value5.00
ROE (%)9.22

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
KRSNAANSE
LTP
1W Low
1W High
Market cap (₹)
8664-174.5 (-1.97%)
8640
8902
1,26,300Cr
992-22.1 (-2.18%)
985.50
1042.10
96,763Cr
725.5-46.15 (-5.98%)
702
784
95,496Cr
911.6-15.15 (-1.63%)
893
929
68,901Cr
790+41.6 (5.56%)
745.05
792.05
68,592Cr
1869-63.1 (-3.27%)
1863
1949.60
38,439Cr
1479.1+6.9 (0.47%)
1410
1500.10
38,149Cr
1877-54.1 (-2.80%)
1855.70
1963
32,259Cr
765.4-5.6 (-0.73%)
748.30
778.55
32,231Cr
510.15+2.35 (0.46%)
502
524.50
16,249Cr
558.05-6 (-1.06%)
545
568.90
1,777Cr

Krsnaa Diagnostics Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹65.22Cr; with other income of ₹7.24Cr, profit before interest and tax came to ₹37.27Cr. Interest expense was ₹14.83Cr; PBT before exceptional items stood at ₹22.43Cr. Basis: consolidated annual results.

Krsnaa Diagnostics Ltd Quaterly Results Key Takeaways

Krsnaa Diagnostics Ltd reported ₹235.53Cr total income from operations in Jun 2026, softer than ₹192.6Cr in Mar 2026 but higher than ₹192.98Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹65.22Cr; with other income of ₹7.24Cr, profit before interest and tax came to ₹37.27Cr. Interest expense was ₹14.83Cr, taking profit before tax to ₹22.43Cr. After tax of ₹5.88Cr, profit after tax stood at ₹16.55Cr (vs ₹41.72Cr in Mar 2026 and ₹20.51Cr in Jun 2025).